Top compounds associated with response to DDX42


Feature Type Standardized
Nominal ANOVA
mRNA nintedanib CTRPv2 pan-cancer AAC 0.039 0.3
mRNA avicin D CTRPv2 pan-cancer AAC 0.057 0.3
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.034 0.3
mRNA Sunitinib FIMM pan-cancer AAC 0.18 0.3
mRNA MST-312 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA Vandetanib FIMM pan-cancer AAC 0.18 0.3
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.039 0.3
mRNA thalidomide CTRPv2 pan-cancer AAC 0.056 0.3
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.043 0.3
Download CSV